![\"\"](\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/08\/shell-game-final-777x437-1.jpg\")
Licensed, Adobe Stock<\/p><\/div><\/p>\n
POSTED BY: PATRICK WOOD
\nTechnocracy News<\/p>\n
In just 24 hours, the mainstream media complex has been flooded with the headline \u201cFull Approval!\u201d for the Pfizer gene therapy injection. Let the vaccine mandates begin!<\/p>\n
Anthony Fauci is thrilled over this news,\u00a0stating<\/a>,\u00a0\u201cyou\u2019re gonna see a lot more [vaccine] mandates because there will be institutions and organizations which previously were reluctant to require vaccinations, which will now feel much more empowered to do that.\u201d\u00a0<\/em><\/p>\n But wait. Something is not adding up with this new stampede to get the needle into your arm.<\/p>\n First, the drug giant Pfizer did not directly develop its mRNA shot: it hired a German company in 2018, BioNTech, to do that for them. They subsequently entered into a joint marketing\/manufacturing agreement to deliver the resulting product to the world. Thus BioNTech is not a subsidiary of Pfizer. According to their joint\u00a02018 press release<\/a>, we learn that:<\/p>\n \u201cUnder the terms of the agreement, BioNTech and Pfizer will jointly conduct research and development activities to help advance mRNA\u2010based flu vaccines. Pfizer will assume sole responsibility for further clinical development and commercialization of mRNA\u2010based flu vaccines, following BioNTech\u2019s completion of a first in human clinical study.\u201d<\/em><\/p>\n The latter human clinical study is what was delivered to the FDA for evaluation, on behalf of BioNTech, in order to get FDA \u201capproval\u201d. BioNTech named the shot Comirnaty. Pfizer has not conducted its own trial, much less submitted it to the FDA.<\/p>\n Because of the contractual development agreement between the two companies, it is unclear that the BioNTech shot is identical to whatever Pfizer is distributing in America, or anywhere else, for that matter. Nevertheless, the media and the FDA promote Pfizer\/BioNTech without making any distinctions between the two.<\/p>\n What was \u201capproved\u201d by the FDA on Monday (8\/23) was Comirnaty, which belongs to the BioNTech side of the Pfizer\/BioNTech working agreement.<\/p>\n In other words, Pfizer is not even in the picture for approval and continues to sell its version of the shot under the Emergency Use Authorization. To repeat, Pfizer has no approval for any mRNA vaccine.<\/p>\n Now, there are a boatload of problems with BioNTech\u2019s application and the FDA\u2019s treatment of it. Medical experts who are examining BioNTech\u2019s human clinical study are quite alarmed. I don\u2019t want to address those issues here, but a detailed analysis is forthcoming.<\/p>\n This report will only point out the duplicitous behavior of the FDA and the mainstream media in promoting this falsehood that Pfizer\u2019s shot has full FDA approval.<\/p>\n To that end, I located the FDA\u2019s\u00a0official press release<\/a>\u00a0dated August 23, 2021 that was titled, \u201cFDA Approves First COVID-19 Vaccine.\u201d We can give them credit for getting the title correct, but the rest of the text is convoluted. We only need to look at the first paragraph to see what has happened:<\/p>\n Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and\u00a0will now be marketed as Comirnaty<\/strong>\u00a0(koe-mir\u2019-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older.\u00a0The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.\u00a0<\/strong><\/em>[emphasis added]<\/p>\n To say that the \u201cvaccine has been known as\u201d is not a specific name designated by the FDA or anyone else. It should be BioNTech only because they hold the product name Comirnaty. To be clear, Comirnaty has received FDA approval.<\/p>\n In the next sentence, the FDA says \u201cThe vaccine also continues to be available under emergency use authorization (EUA)\u201d\u00a0<\/strong><\/em>Do you see that they are talking about two separate products? The second instance belongs to Pfizer and the former to BioNTech. The Pfizer shot is NOT approved and continues as before under EUA.<\/p>\n There is another distinctive that proves this point. Comirnaty is approved for individuals 16 years of age and older. The EUA drug is authorized for individuals 12 through 15.<\/p>\n